ASND icon

Ascendis Pharma
ASND

Overview Fund Activity

187 hedge funds and large institutions have $8.05B invested in Ascendis Pharma in 2022 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 69 increasing their positions, 69 reducing their positions, and 22 closing their positions.

Holders
187
Holders Change
+5
Holders Change %
+2.75%
% of All Funds
3.02%
Holding in Top 10
20
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+25%
% of All Funds
0.32%
New
30
Increased
69
Reduced
69
Closed
22
Calls
$110M
Puts
$23.3M
Net Calls
+$86.4M
Net Calls Change
-$118M

Top Buyers

1
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$345M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$78.2M
3
SI
3
Sofinnova Investments
California
$108M
4
ACA
4
Avoro Capital Advisors
New York
$379M
5
Capital International Investors
5
Capital International Investors
California
$191M

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$445M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$373M
3
RCM
3
RA Capital Management
Massachusetts
$850M
4
EAM
4
Eventide Asset Management
Massachusetts
$95.6M
5
Goldman Sachs
5
Goldman Sachs
New York
$308M
Name Holding Trade Value Shares
Change 		Shares
Change %
DTL
201
Dynamic Technology Lab
Singapore
– -$299K -2,890 Closed
GC
202
Guggenheim Capital
Illinois
– -$265K -2,571 Closed
OWM
203
OneAscent Wealth Management
Alabama
– -$227K -2,202 Closed
WT
204
Whittier Trust
California
– -$9K -87 Closed
BCM
205
Bourgeon Capital Management
Connecticut
– -$9K -84 Closed
BBHC
206
Brown Brothers Harriman & Co
New York
– -$8K -80 Closed
EC
207
Elequin Capital
New York
– -$8K -76 Closed
5 6 7 8
9